Physician

Robert A Graor, MD

According to 2025 Medicare claims, Robert Graor, MD (NPI: 1114926409) practices cardiology in the Las Cruces, NM market, with the plurality of this provider's patient population coming from Dona Ana, NM. This provider's primary affiliated billing organization is THREE CROSSES REGIONAL HOSPITAL LLC (NPI: 1487248050; TIN: 852388743) and primary practice location at 88001-1170. Graor is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Graor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,954 traditional Medicare patients, billed 7,080 HCPCS/CPT codes, and received $466,434 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 4,361 prescription claims across 700 beneficiaries totaling $806,113 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 13 claims. Open Payments data shows 54 records totaling $1,399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $236,593 to $806,113. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,784 to $3,230.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	935	4,099	$413,151
2016	1,039	4,346	$434,391
2017	1,180	4,536	$424,104
2018	1,362	5,267	$437,420
2019	1,282	4,667	$375,237
2020	669	3,365	$476,443
2021	715	3,610	$439,536
2022	1,004	4,796	$368,712
2023	1,622	6,733	$464,698
2024	1,954	7,080	$466,434

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	454	3,360	$236,593
2016	416	3,016	$247,635
2017	411	2,819	$241,240
2018	466	2,994	$227,955
2019	443	3,074	$324,721
2020	387	2,704	$273,969
2021	362	2,371	$235,966
2022	404	2,332	$285,915
2023	565	3,177	$435,838
2024	700	4,361	$806,113

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	186	$16,925
2016	14	218	$11,693
2017	N/R	133	$4,722
2018	N/R	98	$5,101
2019	N/R	39	$2,219
2020	N/R	23	$1,490
2021	N/R	13	$1,363
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	283	283	$213
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	892	1,555	$82
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,041	1,111	$63
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	180	180	$46
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	820	1,104	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	298	21,895	$397,817
Entresto	Sacubitril/Valsartan	147	10,232	$221,359
Xarelto	Rivaroxaban	42	3,148	$53,875
Repatha Sureclick	Evolocumab	52	2,418	$45,483
Flecainide Acetate	Flecainide Acetate	176	15,132	$8,196

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,399	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert A. Graor, MD?

Tedicare shows public-source Medicare data for Robert A. Graor, MD (NPI 1114926409), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert A. Graor, MD have ACO affiliation data?

Robert A. Graor, MD is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Robert A. Graor, MD?

Robert A. Graor, MD is linked to THREE CROSSES REGIONAL HOSPITAL LLC (billing NPI 1487248050) in the available physician profile data.

Does Robert A. Graor, MD have Open Payments data?

Robert A. Graor, MD has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.